- So What?
- Posts
- McKinsey Partner sues firm amidst opioid scandal
McKinsey Partner sues firm amidst opioid scandal
PLUS: Top MBA program's brutal employment stats
Learn AI in 5 minutes a day
This is the easiest way for a busy person wanting to learn AI in as little time as possible:
Sign up for The Rundown AI newsletter
They send you 5-minute email updates on the latest AI news and how to use it
You learn how to become 2x more productive by leveraging AI
Happy Monday and Happy New Year!

Top story: Former McKinsey Partner sues the firm amidst opioid scandal

Source: Getty Images
Defamation Claim: Former McKinsey partner Arnab Ghatak alleges the firm defamed him, scapegoating him for its opioid consulting scandal after a $650M settlement with the DOJ.
Key Dispute: Fired in 2021 for a document deletion discussion, Ghatak denies wrongdoing, contrasting with another partner who pled guilty to obstruction.
Legal Showdown: McKinsey calls the claims baseless and seeks arbitration, while a judge will decide next month if Ghatak’s expanded lawsuit can proceed.
Even McKinsey seems to have scapegoats.
Former McKinsey partner Arnab Ghatak is expanding his lawsuit against the firm, claiming defamation and wrongful termination tied to its controversial opioid consulting work. This follows McKinsey’s $650 million settlement with the U.S. Department of Justice over allegations it aided healthcare fraud and obstructed justice while advising Purdue Pharma and other opioid makers.
Ghatak alleges McKinsey Managing Partner Bob Sternfels defamed him in a memo sent to staff and alumni, falsely accusing him of discussing document deletion. Ghatak and another partner, Martin Elling, were fired in 2021 for violating professional standards. While Elling admitted to deleting files and recently pled guilty to obstruction, Ghatak denies wrongdoing, citing the DOJ’s lack of action against him as vindication.
Ghatak claims McKinsey scapegoated him during its initial 2021 opioid settlement, which was part of over $1.6 billion in payments tied to the opioid crisis. The firm has apologized for its role, adopted stricter policies, and maintains Ghatak’s claims are baseless. A New York judge will soon decide whether the expanded lawsuit can proceed.
Read more here.
Gossip roundup


CEOs be like ‘yeah we’ll deal with AI next year’






That’s all for now - we will circle back next week for another edition of So What? Use the poll below to tell us how we did 👇
How did we do this week? |

It would be crazy not to tell a few of your consulting friends about this newsletter, right?
We’ll send you two pretty spicy McKinsey decks when you refer just one person. Use the link below to refer!
If you are interested in advertising with us, send an email to [email protected]